Camilla Falivena

Government, Health and Not for Profit


Latest publications

ROGNONI C., FALIVENA C., COSTA F., ARMENI P. Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy PharmacoEconomics, 2023, vol.41, pp.209–225
Brunelli S., Murzakhmetova A., FALIVENA C. Environmental Auditing in Rural Areas: Current Patterns and Future Challenges in Central Asia Sustainability, 2022, vol.14, no. 22, pp.15163
Brunelli S., FALIVENA C., Carlino C., Venuti F. Accountability for climate change: a research synthesis through the lenses of the integrated thinking approach Meditari Accountancy Research, 2021, vol.29, no. 4, pp.1005-1038
Stegbauer C., FALIVENA C., Moreno A., Hentschel A., Rosenmöller M., Heise T., Szecsenyi J., Schliess F. Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies BMC Health Services Research, 16 November, 2020, vol.20, no. 1
D'Amato A., FALIVENA C. Corporate social responsibility and firm value: Do firm size and age matter? Empirical evidence from European listed companies Corporate Social Responsibility and Environmental Management, 2020, vol.27, no. 2, pp.909-924
BRUNELLI S., FALIVENA C., ANSELMI L. Applicazione e potenziamento del PIP (Pandemic Influenza Preparedness Framework) in ambito OMS: un’arma in più per affrontare le fasi successive al picco da Covid-19 Mecosan, 2020, vol.113, pp.9-15

Related Articles

Next generation and accrual accounting: the challenges of...
Required time 7 min